Semi-Annual Consolidated Statement Of Cash Flows

TAKARA BIO INC. - Filing #7352210

Concept 2023-04-01 to
2023-12-31
As at
2023-12-31
As at
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
As at
2022-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
3,086,000,000 JPY
22,189,000,000 JPY
Interest and dividends received
133,000,000 JPY
80,000,000 JPY
Interest paid
-16,000,000 JPY
-18,000,000 JPY
Income taxes paid
-2,286,000,000 JPY
-9,641,000,000 JPY
Net cash provided by (used in) operating activities
482,000,000 JPY
13,261,000,000 JPY
Cash flows from investing activities
Other, net
-6,000,000 JPY
8,000,000 JPY
Net cash provided by (used in) investing activities
-11,740,000,000 JPY
-9,551,000,000 JPY
Cash flows from financing activities
Dividends paid
-5,048,000,000 JPY
-3,967,000,000 JPY
Net cash provided by (used in) financing activities
-5,184,000,000 JPY
-4,076,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
1,146,000,000 JPY
1,418,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-15,296,000,000 JPY
1,052,000,000 JPY
Cash and cash equivalents
33,761,000,000 JPY
49,058,000,000 JPY
23,212,000,000 JPY
22,160,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.